| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Krainer Adrian R. is a Director at Stoke Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $9.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | STOK Stoke Therapeutics, Inc. | Director | Sell | 33,243 | $39.74 | $1,320,963.79 | -10.5% | - | - | |
| Nov 24, 2025 | STOK Stoke Therapeutics, Inc. | Director | Sell | 40,472 | $29.72 | $1,202,718.57 | -11.1% | +19.4% | - | |
| Nov 14, 2025 | STOK Stoke Therapeutics, Inc. | Director | Sell | 40,472 | $26.98 | $1,092,058.26 | -5.1% | +20.3% | - |